A Rational Design of α-Helix-Shaped Peptides Employing the Hydrogen-Bond Surrogate Approach: A Modulation Strategy for Ras-RasGRF1 Interaction in Neuropsychiatric Disorders

Abstract

In the last two decades, abnormal Ras (rat sarcoma protein)–ERK (extracellular signal-regulated kinase) signalling in the brain has been involved in a variety of neuropsychiatric disorders, including drug addiction, certain forms of intellectual disability, and autism spectrum disorder. Modulation of membrane-receptor-mediated Ras activation has been proposed as a potential target mechanism to attenuate ERK signalling in the brain. Previously, we showed that a cell penetrating peptide, RB3, was able to inhibit downstream signalling by preventing RasGRF1 (Ras guanine nucleotide-releasing factor 1), a neuronal specific GDP/GTP exchange factor, to bind Ras proteins, both in brain slices and in vivo, with an IC50 value in the micromolar range. The aim of this work was to mutate and improve this peptide through computer-aided techniques to increase its inhibitory activity against RasGRF1. The designed peptides were built based on the RB3 peptide structure corresponding to the α-helix of RasGRF1 responsible for Ras binding. For this purpose, the hydrogen-bond surrogate (HBS) approach was exploited to maintain the helical conformation of the designed peptides. Finally, residue scanning, MD simulations, and MM-GBSA calculations were used to identify 18 most promising α-helix-shaped peptides that will be assayed to check their potential activity against Ras-RasGRF1 and prevent downstream molecular events implicated in brain disorders.

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection

“…The analysis of these results suggested that the complex involving PDB 2ZHN and 6MEJ registered a higher number of key interactions between the galectin-9 CRDs and the E2 branched oligosaccharide. Furthermore, in order to explore the contacts between galectin-9 and E2 amino acids, the two MD simulations were processed by clustering the MD frames in 10 clusters per trajectory [ 64 ]. The centroids of each cluster were thus analyzed to deepen the single amino acid role in the complex stabilization ( Supplementary Table S2 ).…”

Stabilized cyclic peptides as modulators of protein–protein interactions: promising strategies and biological evaluation

“…77 A panel of HBS-modified peptides were designed and synthesized based on the peptide sequence derived from the α-helix portion of RasGRF1 (Ras guanine nucleotide-releasing factor 1) at the Ras protein binding interface, which showed great potency for inhibiting Ras-RasGRF1 interaction and thus disturbing the downstream signaling pathway implicated in brain disorders. 78 Later, the remarkable efficacy of the HBS strategy was demonstrated by rational design and functional assessment of HBS-stabilized peptides to block the interaction of the p300/CBP coactivator with the transcription factor HIF-1α. 79 In another case, HBS helices that mimic the Bak BH3 domain were demonstrated to target the protein Bcl-xL with high affinities.…”

Identification of the Interaction Domains in the ENO1/Hsp70 Complex, Delve into Novel Potential Therapeutic Target

“…In 2013, Beard et al demonstrated a correlation between the experimental alanine scanning results and the computational ones obtained though Schrödinger suite. Indeed, a residue can be considered as an interaction hot spot, if its mutation to alanine generates a ∆∆G a nity ≥ 3.0 kcal/mol [44][45][46]. Table 2 lists the ∆∆G a nity values for Hsp70 amino acids registering ∆∆G a nity ≥ 3.0 kcal/mol.…”